Plasma concentrations of brain natriuretic peptide (BNP), an agonist of GC-A, are in correlation to cognitive function in demented patients and are associated with increased risk of developing cognitive disorders (Naito et al., 2009). This evidence concerns the gene NPPB and cognitive disorder.